The subcutaneous adipose transcriptome identifies a molecular signature of insulin resistance shared with visceral adipose

Mona Mashayekhi,Quanhu Sheng,Samuel S Bailin,Lucas Massier,Jiawei Zhong,Mingjian Shi,Celestine N Wanjalla,Thomas J Wang,T Alp Ikizler,Kevin D Niswender,Curtis L Gabriel,Julia Palacios,Rachel Turgeon-Jones,Cassandra F Reynolds,James M Luther,Nancy J Brown,Saumya Das,Ingrid Dahlman,Jonathan D Mosley,John R Koethe,Mikael Rydén,Katherine N Bachmann,Ravi V Shah

DOI: https://doi.org/10.1002/oby.24064

Abstract:Objective: The objective of this study was to identify the transcriptional landscape of insulin resistance (IR) in subcutaneous adipose tissue (SAT) in humans across the spectrum of obesity. Methods: We used SAT RNA sequencing in 220 individuals with metabolic phenotyping. Results: We identified a 35-gene signature with high predictive accuracy for homeostatic model of IR that was expressed across a variety of non-immune cell populations. We observed primarily "protective" IR associations for adipocyte transcripts and "deleterious" associations for macrophage transcripts, as well as a high concordance between SAT and visceral adipose tissue (VAT). Multiple SAT genes exhibited dynamic expression 5 years after weight loss surgery and with insulin stimulation. Using available expression quantitative trait loci in SAT and/or VAT, we demonstrated similar genetic effect sizes of SAT and VAT on type 2 diabetes and BMI. Conclusions: SAT is conventionally viewed as a metabolic buffer for lipid deposition during positive energy balance, whereas VAT is viewed as a dominant contributor to and prime mediator of IR and cardiometabolic disease risk. Our results implicate a dynamic transcriptional architecture of IR that resides in both immune and non-immune populations in SAT and is shared with VAT, nuancing the current VAT-centric concept of IR in humans.